| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |